Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma

NCT01951365

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Seoul National University Bundang Hospital Seongnam, Kyenggi, South Korea

Seoul Natl. Univ. Hospital Seoul, South Korea

View Trial Details

Completed

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

NCT00395070

Conditions: Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations: Location #40 Tucson, Arizona, United States

Location #9 Little Rock, Arkansas, United States

Location #1 Bakersfield, California, United States

Location #24 San Diego, California, United States

View all 88 locations

View Trial Details

Completed

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

NCT00498836

Conditions: Malignant Melanoma, Melanoma, Neoplasm Metastasis, +14 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

Cancer Therapy and Research Center, Institute for Drug Development San Antonio, Texas, United States

The Norwegian Radium Hospital Oslo, Norway

Lund University Hospital Lund, Sweden

View Trial Details

Completed

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma

NCT00004141

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

NCT00004153

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

NCT00002952

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

NCT00203879

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma

NCT01743157

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: San Francisco Oncology Associates San Francisco, California, United States

View Trial Details

Completed

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

NCT00014456

Conditions: AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +100 more
Locations: Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

NCT00246012

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Scottsdale, Arizona, United States

La Jolla, California, United States

Santa Monica, California, United States

Walnut Creek, California, United States

View all 32 locations

View Trial Details